The Great Debate at 'Immunotherapy Bridge', Naples, December 5, 2019

Paolo A. Ascierto, Carlo Bifulco, Jerome Galon, Claus Garbe, Samir N. Khleif, Jennifer McQuade, Kunle Odunsi, Hideho Okada, Chrystal M. Paulos, Sergio A. Quezada, Hussein A. Tawbi, John Timmerman, Giorgio Trinchieri, Lisa H. Butterfield, Igor Puzanov

Research output: Contribution to journalArticlepeer-review


As part of the 2019 Immunotherapy Bridge congress (December 4-5, Naples, Italy), the Great Debate session featured counterpoint views from leading experts on six topical issues in immunotherapy today. These were the use of chimeric antigen receptor T cell therapy in solid tumors, whether the Immunoscore should be more widely used in clinical practice, whether antibody-dependent cellular cytotoxicity is important in the mode of action of anticytotoxic T-lymphocyte-associated protein 4 antibodies, whether the brain is immunologically unique or just another organ, the role of microbiome versus nutrition in affecting responses to immunotherapy, and whether chemotherapy is immunostimulatory or immunosuppressive. Discussion of these important topics are summarized in this report.

Original languageEnglish
JournalJournal for ImmunoTherapy of Cancer
Issue number2
Publication statusPublished - Aug 1 2020


  • chimeric antigen
  • CTLA-4 antigen
  • cytotoxicity
  • immunologic
  • immunotherapy
  • receptors

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Molecular Medicine
  • Oncology
  • Pharmacology
  • Cancer Research


Dive into the research topics of 'The Great Debate at 'Immunotherapy Bridge', Naples, December 5, 2019'. Together they form a unique fingerprint.

Cite this